Our Story
Experts in single-cell science, -omics analytics, and AI.
Our new and emerging analytical device produces rich data-sets by measuring hundreds of parameters from millions of individual cells. The resulting single-cell data holds the information needed for early disease detection, but it requires sophisticated and innovative computational approaches in order to extract the relevant information.
Scailyte is an ETH Zürich spin-off with a best-in-class artificial intelligence platform for the discovery of complex disease patterns from single-cell data. Our solution provides unprecedented insight into the disease and patients’ biology and enables the discovery of new clinically-relevant biomarker signatures by uncovering human’s hidden “single-cell” secrets. Scailyte’s proprietary best-in-class data analysis platform ScaiVision™ associates multimodal single-cell datasets (RNA-/TCR-/BCR-seq, proteomics, etc.) with clinical endpoints, such as disease diagnosis, progression, severity, treatment response, and toxicity response to identify ultra-sensitive biomarker signatures and cell functionality states. The performance and clinically-relevant applications of Scailyte’s platform ScaiVision have been demonstrated in well established CAR-T cell therapies and various clinical projects in Oncology and Immunology.
We are addressing this problem by developing artificial intelligence (AI) software for single-cell data analysis. The underlying best-in-class algorithms allow us to associate patterns in single-cell data with disease status.
We provide a powerful software solution (ScaiVision), unifying our AI technology for the global medical community and delivering it to those working in drug and diagnostic R&D.
Mission
Our mission is to advance precision medicine with single-cell technologies, artificial intelligence, and multiomics analysis.
Vision
To save lives by enabling precision medicine.
Meet Our Team
Dr. Peter Nestorov
Peter holds a PhD in Genetics from the University of Basel and a degree in Biochemistry from the University of Tübingen. He has been working in the emerging single-cell analysis market since 2015 and this gave him the inspiration to start Scailyte as co-founder and CEO in 2017.
Dr. Corinne Solier
SVP Corporate & Technology Development
Corinne obtained a Masters in Engineering Sciences in Biotechnology and a PhD in Immunology from Université Paul Sabatier in Toulouse, France. She pursued postdoctoral studies at the City of Hope National Medical Center in the U.S.A. in the field of nuclear receptor biochemistry before joining Roche Pharmaceuticals. There, she held various positions in early research and development, intersecting with translational biomarker science, cutting-edge “omics” technologies and innovation. She joined Scailyte in 2021 as Chief Operating Officer.
Dr. Sarah Carl
Director Data Science
Sarah holds a PhD in Genetics from the University of Cambridge. She worked as a bioinformatician at the Friedrich Miescher Institute in Basel, Switzerland, for four years before joining Scailyte. Sarah joined Scailyte as a data scientist in 2018 and now serves as Director of Data Science.
Diana Stoycheva
Principal Expert Scientist
Diana is a principal scientist with a Masters in Molecular Biotechnology from the University of Heidelberg. She holds a PhD in immunology from HU Berlin and pursued postdoctoral studies in Immunology at the ETH Zurich. Diana’s strong scientific background reflects her personal passion for immunology, immuno-oncology and specifically cell therapies. She joined Scailyte in 2020, evaluating opportunities to apply our AI to new projects in immunology and immuno-oncology.
Anna Sumeray
Biotech startup CEO, member of the Scailyte Board of Directors
Anna is a global Biotech executive and entrepreneur with broad experience of defining and building successful businesses. Advisor and investor in biotech start-ups, pioneer and general manager of European launch projects and experienced business development leader and negotiator.
Prof. Dr. Michael Mueller, MD
Michael is a renowned gynecologist and gynecological oncologist, and managing director of the Women’s Health Clinic at the University Hospital of Bern (Inselspital). Prof. Mueller is supporting Scailyte as a clinical advisor and expert in endometriosis and women’s health.
Prof. Dr. Petter Brodin, MD
Petter is a pioneer in single-cell analysis and, advising Scailyte in immunology and the application of single-cell technologies for clinical research. Prof. Brodin is based at the Karolinska Institute in Sweden and heads a research group that focuses on systems-level analyses of the human immune system. Prof. Brodin is a consultant pediatrician working at the Karolinska University Hospital.
Prof. Dr. Tomas Kalina MD
Tomas is a physician and a cytometry expert currently leading a research group focused on disorders of adaptive immunity at the Charles University in Prague. Professor Kalina is supporting Scailyte as a clinical diagnostic advisor with his expertise in cytometry standardization.
Join the Scailyte team
Are you ready to help us transform biomedical research and healthcare? Please send us your CV, and your letter of motivation to join Scailyte, in an email to: careers@scailyte.com
Become part of something great.
To achieve our mission, we are looking for smart, passionate and dedicated individuals who share our values by dreaming big, to join our growing, energetic and fun team. We offer flexible working schedules and location.
Recent News
Recent News
Future Labs Live 2023
Scailyte will be attending the Future Labs Live event, taking place from 31st May to 2nd June 2023 a...
Recent News
The psychological and economic impact of endometriosis
We're thrilled to present the third episode of Scailyte's Endometriosis Awareness Series, where Cinz...
Recent News
Jan Lichtenberg joins Scailyte's Board of Directors
Scailyte, a biomarker discovery company leveraging single-cell omics and artificial intelligence, is...
Recent News
Challenges and opportunities for innovation in Endometriosis
Join us for the second episode of the Endometriosis Awareness Series on “Challenges and opportunit...
Recent News
Swiss Biotech Day 2023
Sarah Carl will be a panellist at the Swiss Biotech Association's Swiss Biotech Day 2023 on April 24...
Recent News
Deciphering Disease Mechanisms Through Functional Genomics
Tiwari lab studies gene-epigenetic interplay in cell identity & its disruption in cancer/neurologica...
Recent News
Women's Health Innovation Summit
Exciting news from Scailyte! We are thrilled to announce that we have been selected among the top 15...
Recent News
ISCT 2023
Diana Stoycheva and Filipa Teixeira will be attending the ISCT 2023 Annual Meeting from 31st May to ...
Future Labs Live 2023
Scailyte will be attending the Future Labs Live event, taking place from 31st May to 2nd June 2023 a...
Recent News
The psychological and economic impact of endometriosis
We're thrilled to present the third episode of Scailyte's Endometriosis Awareness Series, where Cinz...
Jan Lichtenberg joins Scailyte's Board of Directors
Scailyte, a biomarker discovery company leveraging single-cell omics and artificial intelligence, is...
Recent News
Challenges and opportunities for innovation in Endometriosis
Join us for the second episode of the Endometriosis Awareness Series on “Challenges and opportunit...
Swiss Biotech Day 2023
Sarah Carl will be a panellist at the Swiss Biotech Association's Swiss Biotech Day 2023 on April 24...
Recent News
Deciphering Disease Mechanisms Through Functional Genomics
Tiwari lab studies gene-epigenetic interplay in cell identity & its disruption in cancer/neurologica...
Women's Health Innovation Summit
Exciting news from Scailyte! We are thrilled to announce that we have been selected among the top 15...
Are you ready to help us transform biomedical research and healthcare? Please send us your CV, and your letter of motivation to join Scailyte, in an email to: careers@scailyte.com